http://orcid.org/0000-0001-5545-5983
About the Authors
- Brook C. Barajas
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Validation, Writing – review & editing
Affiliation Department of Global Health, University of Washington, Seattle, WA, United States of America
- Motoko Tanaka
-
Roles Formal analysis, Investigation, Methodology, Validation, Writing – review & editing
Affiliation Department of Global Health, University of Washington, Seattle, WA, United States of America
- Bridget A. Robinson
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Validation, Writing – review & editing
Affiliation Department of Global Health, University of Washington, Seattle, WA, United States of America
- Daryl J. Phuong
-
Roles Resources
Affiliation Department of Global Health, University of Washington, Seattle, WA, United States of America
- Kasana Chutiraka
-
Roles Resources
Affiliation Department of Global Health, University of Washington, Seattle, WA, United States of America
- Jonathan C. Reed
-
Roles Conceptualization, Formal analysis, Investigation, Resources, Validation, Writing – review & editing
Affiliation Department of Global Health, University of Washington, Seattle, WA, United States of America
- Jaisri R. Lingappa
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
* E-mail: jais@uw.edu
Affiliation Department of Global Health, University of Washington, Seattle, WA, United States of America
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: JRL owns founder shares in Prosetta Biosciences and has received some unrestricted research funding from Prosetta Biosciences. JCR owns shares in Prosetta Biosciences. However, the studies reported here were not funded by Prosetta and likely do not pose a conflict of interest for me because they do not relate directly to any of Prosetta’s antiviral compounds. The authors have no additional competing financial interests to declare.